Results 111 to 120 of about 28,516 (205)

Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1. [PDF]

J Biol Chem, 2015
Gong L, Liu M, Zeng T, Shi X, Yuan C, Andreasen PA, Huang M.   +6 more
europepmc   +1 more source

Basic mechanisms and regulation of fibrinolysis [PDF]

, 2015
Kolev, Kraszimir Nikolaev, Longstaff, Colin   +1 more
core   +1 more source

Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop. [PDF]

Protein Sci, 2016
Qureshi T, Goswami S, McClintock CS, Ramsey MT, Peterson CB.   +4 more
europepmc   +1 more source

Plasminogen activators in ischemic stroke: introduction. [PDF]

Stroke, 2010
del Zoppo GJ.
europepmc   +1 more source

Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma. [PDF]

Exp Eye Res, 2016
Chintala SK.
europepmc   +1 more source

Clotting and other plasma factors in experimental endotoxemia: inhibition of degradation by exogenous proteinase inhibitors. [PDF]

, 1981
Fritz, Hans, Jochum, Marianne, Ruckdeschl, G., Schießler, Hans, Selbmann, H. K., Witte, J.   +5 more
core   +1 more source

Physiopathology of fibrinolysis in sepsis-induced disseminated intravascular coagulation: Emerging mechanisms and pharmacological targets. [PDF]

Ann Intensive Care
Tschirhart M, Martin M, Curtiaud A, Angles-Cano E, Meziani F, Toti F, Helms J.   +6 more
europepmc   +1 more source

Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis. [PDF]

Pharmaceuticals (Basel)
Shibeko AM, Nikitin NS, Podoplelova NA, Manuvera VA, Lazarev VN.   +4 more
europepmc   +1 more source

COX-2/PGE₂ signaling drives Toxocara canis-induced lung pathology by enhancing plasminogen activator activity and collagen VI degradation. [PDF]

Sci Rep
Lai SC, Lu CY, Chuang CY, Lee HH, Lee MC, Chen KM.   +5 more
europepmc   +1 more source